The latest Wolfson Research Institute for Health and Wellbeing Newsletter should be arriving in your inbox this morning.

The latest Wolfson Research Institute for Health and Wellbeing Newsletter should be arriving in your inbox this morning.

The latest Wolfson Research Institute for Health and Wellbeing Newsletter should be arriving in your inbox this morning.

The latest Wolfson Research Institute for Health and Wellbeing Newsletter should be arriving in your inbox this morning.

The latest Wolfson Research Institute for Health and Wellbeing Newsletter should be arriving in your inbox this morning.

The latest Wolfson Research Institute for Health and Wellbeing Newsletter should be arriving in your inbox this morning.

The latest Wolfson Research Institute for Health and Wellbeing Newsletter should be arriving in your inbox this morning.

Building on the positive clinical and safety data from its lead drug nomacopan, Akari is developing a second related therapeutic candidate (votucalis) focusing on new clinical targets. Votucalis captures histamine and thereby has the unique potential to prevent activation of all four histamine G-protein coupled receptors (GPCRs) which can induce diverse pathophysiological processes, including chronic pain, itch and inflammation.

Welcome to Footsteps Festival 2021, a year-long celebration of living well with pain. Developed by people who live with pain, academics and professionals in pain management, Footsteps Festival takes a creative approach to living well with persistent pain.

Another Community event which we are planning at the moment (with Katie Binks and Durham Parkinsons UK branch)

The latest Wolfson Research Institute for Health and Wellbeing Newsletter should be arriving in your inbox this morning.

Dynamo’s Health & Social Care Tech Cluster invites all innovative SMEs, VCSEs, academics and health & social care professionals to get involved in our Population Health Design Sprint: 26 May 09.30 – 14.30